Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-20-014754
Filing Date
2020-06-12
Accepted
2020-06-12 07:49:44
Documents
26

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS f424b40620_lanternpharm.htm 424B4 4483701
2 GRAPHIC lantern_logo.jpg GRAPHIC 52886
3 GRAPHIC image_002.jpg GRAPHIC 1800056
4 GRAPHIC image_003.jpg GRAPHIC 584360
5 GRAPHIC image_004.jpg GRAPHIC 274908
6 GRAPHIC image_005.jpg GRAPHIC 788769
7 GRAPHIC image_005a.jpg GRAPHIC 653668
8 GRAPHIC image_007.jpg GRAPHIC 522130
9 GRAPHIC image_008.jpg GRAPHIC 569893
10 GRAPHIC image_009.jpg GRAPHIC 399932
11 GRAPHIC image_010.jpg GRAPHIC 559055
12 GRAPHIC image_011.jpg GRAPHIC 275395
13 GRAPHIC image_013.jpg GRAPHIC 52297
14 GRAPHIC image_014.jpg GRAPHIC 301519
15 GRAPHIC image_015.jpg GRAPHIC 424324
16 GRAPHIC image_016.jpg GRAPHIC 806461
17 GRAPHIC image_016a.jpg GRAPHIC 61921
18 GRAPHIC image_017.jpg GRAPHIC 417678
19 GRAPHIC image_018.jpg GRAPHIC 188581
20 GRAPHIC image_019.jpg GRAPHIC 265758
21 GRAPHIC image_020.jpg GRAPHIC 253741
22 GRAPHIC image_021.jpg GRAPHIC 86813
23 GRAPHIC image_022.jpg GRAPHIC 100389
24 GRAPHIC image_023.jpg GRAPHIC 264025
25 GRAPHIC image_024.jpg GRAPHIC 255793
26 GRAPHIC image_025.jpg GRAPHIC 62848
  Complete submission text file 0001213900-20-014754.txt   18178361
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-237714 | Film No.: 20958874
SIC: 2834 Pharmaceutical Preparations